|
CENPH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.263700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.627990E-02 |
| Normal-vs-Stage2 |
9.652200E-01 |
| Normal-vs-Stage3 |
1.376410E-03 |
| Normal-vs-Stage4 |
7.799300E-03 |
| Stage1-vs-Stage2 |
8.950700E-04 |
| Stage1-vs-Stage3 |
1.995610E-01 |
| Stage1-vs-Stage4 |
2.226800E-01 |
| Stage2-vs-Stage3 |
3.208300E-04 |
| Stage2-vs-Stage4 |
1.681280E-03 |
| Stage3-vs-Stage4 |
8.067000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.598600E-04 |
| Normal-vs-AfricanAmerican |
1.044640E-01 |
| Normal-vs-Asian |
3.325600E-02 |
| Caucasian-vs-AfricanAmerican |
6.968200E-01 |
| Caucasian-vs-Asian |
4.213200E-01 |
| AfricanAmerican-vs-Asian |
9.221400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.142300E-02 |
| Normal-vs-Female |
4.224000E-03 |
| Male-vs-Female |
9.455000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.840000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.244100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.223800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.906000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.949770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.641200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.882800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.513800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.664000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.041200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.151600E-01 |
| Classical-VS-Follicular |
5.35270050505687E-10 |
| Classical-VS-Other |
2.061000E-01 |
| Classical-VS-Normal |
8.607000E-04 |
| Tall-VS-Follicular |
1.2665999999939E-06 |
| Tall-VS-Other |
5.789900E-02 |
| Tall-VS-Normal |
5.195500E-04 |
| Follicular-VS-Other |
4.148200E-01 |
| Follicular-VS-Normal |
5.796200E-01 |
| Other-VS-Normal |
7.072600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.527500E-02 |
| Normal-vs-N1 |
7.581500E-03 |
| N0-vs-N1 |
8.042200E-02 |
|
|
